Scinovex
article Open AccessTop 1% cited

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

Molecular and Cellular Biology · 2008 · Vol. 28(17) · pp. 5369–5380
Galina GabrielyThomas WürdingerSantosh KesariChristine EsauJulja BurchardPeter S. LinsleyAnna M. Krichevsky

Abstract

Substantial data indicate that microRNA 21 (miR-21) is significantly elevated in glioblastoma (GBM) and in many other tumors of various origins. This microRNA has been implicated in various aspects of carcinogenesis, including cellular proliferation, apoptosis, and migration. We demonstrate that miR-21 regulates multiple genes associated with glioma cell apoptosis, migration, and invasiveness, including the RECK and TIMP3 genes, which are suppressors of malignancy and inhibitors of matrix metalloproteinases (MMPs). Specific inhibition of miR-21 with antisense oligonucleotides leads to elevated levels of RECK and TIMP3 and therefore reduces MMP activities in vitro and in a human model of gliomas in nude mice. Moreover, downregulation of miR-21 in glioma cells leads to decreases of their migratory and invasion abilities. Our data suggest that miR-21 contributes to glioma malignancy by downregulation of MMP inhibitors, which leads to activation of MMPs, thus promoting invasiveness of cancer cells. Our results also indicate that inhibition of a single oncomir, like miR-21, with specific antisense molecules can provide a novel therapeutic approach for "physiological" modulation of multiple proteins whose expression is deregulated in cancer.

MicroRNA in disease regulationCircular RNAs in diseasesRNA modifications and cancerBiologyDownregulation and upregulationGliomaCancer researchMatrix metalloproteinasemicroRNAOncomirCarcinogenesisApoptosisCancer

MeSH terms

AnimalsBase SequenceCell MovementEnzyme InhibitorsExtracellular MatrixGliomaHumansMolecular Sequence DataNeoplasm InvasivenessNeoplasm TransplantationRNA, MessengerDown-RegulationGene Expression Regulation, NeoplasticApoptosisDisease Progression

Funding

  • National Institutes of Health
  • National Cancer Institute
Citations
884
FWCI
24.27
field-weighted impact
References
62
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.